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 Summary 
 
The spatial organization of the genome and its dynamics contribute to gene expression 
and cellular function in normal development as well as in disease.  Although we are 
increasingly well equipped to determine a genome’s sequence and linear chromatin 
composition, studying the three-dimensional organization of the genome with high 
spatial and temporal resolution remains challenging.  The 4D Nucleome Network aims 
to develop and apply approaches to map the structure and dynamics of the human and 
mouse genomes in space and time with the long term goal of gaining deeper 
mechanistic understanding of how the nucleus is organized.  The project will develop 
and benchmark experimental and computational approaches for measuring genome 
conformation and nuclear organization, and investigate how these contribute to gene 
regulation and other genome functions.  Further efforts will be directed at applying 
validated experimental approaches combined with biophysical modeling to generate 
integrated maps and quantitative models of spatial genome organization in different 
biological states, both in cell populations and in single cells. 
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Background 
 
The human genome contains tens of thousands of genes, and a much larger number of 
regulatory elements, that collectively encode the program by which we develop and 
function as complex organisms.  Large-scale studies within the last decade have 
extensively cataloged these components of our genome, as well as the cell types and 
tissues in which they are active.  For instance, the ENCODE, Roadmap Epigenome, the 
International Human Epigenome Project and FANTOM projects 1-4 annotated tens of 
thousands of genes and millions of candidate regulatory elements such as enhancers, 
insulators and promoters in the human and mouse genomes.  However, our 
understanding of where and how these elements contribute to gene regulation, 
including the mechanisms by which they exert regulatory effects on specific target 
genes across distances of kilobases to in some cases megabases, is decidedly 
incomplete.   
 
It is increasingly appreciated that the spatial folding of chromosomes and their 
organization in the nucleus have profound regulatory impact on gene expression.  For 
example, spatial proximity is necessary for enhancers to modulate transcription of their 
target genes (e.g. 5-7), and clustering of chromatin near the nuclear lamina is correlated 
with gene silencing and the timing of DNA replication 8,9.  Meanwhile, genome-wide 
association studies (GWAS) have identified large numbers of disease-associated loci, 
and the vast majority of them are located in distal, potentially regulatory, noncoding 
regions (e.g. 10).  These GWAS results not only emphasize the importance of distal 
regulatory elements for genome functions, but also suggest an exciting opportunity to 
uncover fundamental mechanisms of disease through the mapping of long-range 
chromatin interactions and 3D genome organization.  Therefore, to fully determine how 
the genome operates inside living cells, we need to understand not only the linear 
encoding of information along chromosomes, but also its 3-dimensional organization 
and its dynamics across time, i.e. the “4D nucleome”.  Concomitantly, we must pursue 
deeper knowledge of the biophysical and molecular factors that determine genome 
organization, and how this organization contributes to gene regulation and other nuclear 
activities.  
 
Genome conformation is intimately connected to the broader organization of the 
nucleus.  Over a century of microscopy studies have revealed that the nucleus is not a 
homogeneous organelle, but rather consists of distinct nuclear structures and non-
chromatin bodies as well as defined chromosomal regions, such as centromeres, 
telomeres and insulator bodies, recognized to cluster with each other and other 
genomic regions to define distinct nuclear compartments 11-13.  Examples of nuclear 
structures include the nuclear periphery, nuclear pores and the heterochromatic 
compartment 14, while examples of nuclear bodies include nucleoli, nuclear speckles, 
paraspeckles, and Cajal and PML bodies.  Chromosome conformation capture 
approaches 15 have yielded additional insights by characterizing chromatin folding 
genome-wide at kilobase-resolution 6,16-18.  These studies show that the genome is 
compartmentalized in active and inactive spatial compartments at the scale of the 
nucleus, and within each compartment folding of chromatin fibers brings together sets of 
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loci and regulatory elements that are otherwise separated by large genomic distances.  
It is possible that such interactions are at least in part related to and controlled by the 
formation of chromatin domains 17,19,20.  Further evidence suggests that CTCF, the 
cohesin complex, and many other DNA binding proteins as well as noncoding RNAs 
play roles in organizing chromatin domains and long-range interactions between DNA 
loci 17,21-26.  Altogether, these studies point to the genome being intricately organized 
within the nucleus, with this organization playing a critical role in gene regulation and 
activity. 
 
The past decade witnessed significant technological innovation in the area of 
chromosome and nuclear structure analysis.  Genomic approaches for mapping 
chromatin interactions, such as 3C, 4C, 5C, Hi-C, and ChIA-PET, are yielding genome-
wide chromatin interaction maps at unprecedented resolution 18.  Live cell and super-
resolution microscopic approaches, combined with application of new ways (e.g. 
CRISPR/Cas9 –based systems) to visualize chromosome loci and sub-nuclear 
structures are beginning to provide detailed views of the organization and dynamics of 
chromatin inside single (living) cells 27-33.  There has also been tremendous progress in 
modeling and analyzing chromosome structural data, producing structural models for 
chromosome folding which promise to provide biophysical interpretation of these often 
complicated datatypes 34,35.  However, despite this progress, a comprehensive 
understanding of the 4D nucleome is still lacking.  This is partly due to the fact that 
different experimental cell systems and approaches are used, which together with the 
absence of widely shared benchmarks for assay performance have led to observations 
that cannot be directly compared.  Additionally, we currently have limited ability to 
integrate different datatypes (e.g. chromatin interaction data and imaging-based 
distance measurements) and lack approaches that can measure and account for cell-to-
cell variability in chromosome and nuclear organization.  Finally, we continue to lack 
mechanistic insights into the relationships between chromosome conformation and 
nuclear processes including transcription, DNA replication, and chromosome 
segregation.  We believe these major gaps can be addressed by a highly synergistic, 
multidisciplinary and integrated approach in which groups with different expertise and 
knowledge, ranging from imaging and genomics to computer science and physics, work 
closely together to study common cell systems using complementary methods.  
 
 
Overview of the goals and strategy of the project 
 
The 4D Nucleome (4DN) Network aims to develop a set of validated approaches to map 
the structures and dynamics of the genome and to relate these features to its biological 
activities.  The Network aims to generate integrated maps and comprehensive, 
quantitative models of nuclear organization in diverse cell types and conditions, 
including in single cells.  Overall, we anticipate that these efforts will lead to new 
mechanistic insights into how the genome is organized, maintained, expressed, and 
replicated, in both normal and disease states. 
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Specifically, the 4DN Network will 1) develop, benchmark, validate, and standardize a 
wide array of technologies to probe the 4D nucleome; 2) integrate, analyze, and model 
datasets obtained with these technologies to obtain a comprehensive view of the 4DN; 
and 3) investigate the functional role of various structural features of chromatin 
organization in transcription, DNA replication and other nuclear processes. These three 
main components are illustrated in Figure 1. 
 
To achieve these objectives, we have identified the following key steps.  First, a set of 
common cell lines will be studied across the Network to enable direct cross-validation of 
data obtained with different methods (Table 1).  Important criteria for selecting a set of 
common cell lines include a stable, haplotype-phased and normal karyotype, ease of 
growth, ease of genome editing, and suitability for (live-cell) imaging.  Further, given 
that cell populations are characterized by significant cell-to-cell variation in their 
biological state (e.g. cell cycle stage), it will be important to employ clonal cell 
populations that can be synchronized, activated, induced or differentiated in a controlled 
manner.   
 
Second, standards for data formats and data quality will be established so that data can 
be shared and compared among members of the consortium and the scientific 
community.  This includes defining metrics for reproducibility across technical replicates 
(for technology development) and across biological replicates, and an objective 
assessment of the sensitivity, specificity, resolution and precision with which aspects of 
the 4D nucleome can be measured. 
 
Third, computational and analytical tools will be developed to analyze individual 
datasets and to integrate, compare and cross-validate data obtained with different 
technologies.  Importantly, they will allow for the integration of the diverse datasets 
necessary to build comprehensive models of the 4D nucleome. 
 
Fourth, genetic, biochemical and biophysical approaches will be developed to measure 
and perturb the roles of DNA sequences and trans-acting factors (proteins, RNA) in the 
formation of local and global aspects of the 4D nucleome and their impact on 
transcription and other nuclear functions. 
 
Fifth, a common vocabulary will be developed to describe nuclear features and 
biophysically derived principles guiding chromosome folding.  This is important because 
currently different structural descriptions and interpretations have been put forward to 
describe features detected by different technologies, or even by the same methods.  We 
need better descriptions of the underlying reality of structural features that make up the 
4D nucleome, e.g. loops and domains, and develop a consistent terminology as these 
features are detected by different technologies.  This can be achieved by integrated 
analysis of data obtained with the wide range of technologies employed and under 
development by the Network.  This vocabulary, which will also include nomenclature for 
non-chromosomal nuclear features, will be of significant value to the community as a 
whole.  
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Finally, to enhance synergy between the different groups and prevent the unnecessary 
duplication of efforts, and to facilitate rapid dissemination of data to the larger scientific 
community, a shared database and repository will be established which includes all 
data, detailed protocols, engineered cell lines, and reagents used across the Network. 
The Network will build and maintain a public browser for all 4D Nucleome data to enable 
easy access to data and models  
 
 
Structure of the 4D Nucleome Network 
 
The 4DN Network encompasses several related efforts (http://www.4dnucleome.org/; 
Figure 2).  First, six Centers make up the Nuclear Organization and Function 
Interdisciplinary Consortium (NOFIC).  Each of these NOFIC Centers will develop 
genomic and imaging technologies, and implement computational models for 
understanding the 4D Nucleome.  NOFIC centers will also work together with the other 
components of the Network to benchmark the performance of these experimental and 
computational tools, and to identify the most appropriate repertoire of methods to study 
the 4D Nucleome.  These studies will be combined with extensive structural and 
functional validation of observations and models.  Ultimately, the NOFIC aims to deliver 
integrated approaches that can be used towards generating a first draft of a model of 
the 4D nucleome. 
 
Second, ongoing technology development will also be critical to this effort, and is 
addressed by the 4D Nucleome Network in three ways.  (i) New genomic interaction 
technologies will be developed to study the 4D nucleome at the single cell level, for 
example, to detect higher-order clusters of interacting genomic loci, to probe the roles of 
RNA in chromatin architecture, and to engineer new chromatin interactions.  (ii) Several 
groups will develop new imaging and labeling methods to visualize the genome at high 
resolution, in live cells as well as in tissues, and in relation to genome activity.  (iii) New 
methods will be developed to probe the DNA, RNA and protein composition of 
subnuclear structures such as the nuclear envelope, the nucleolus and other nuclear 
bodies.  These methods, including procedures to reversibly disrupt these structures, will 
allow mechanistic studies of the role of nuclear bodies/structures in chromatin 
organization and gene expression under various conditions of health and disease.  
 
Third, a Data Coordination and Integration Center (DCIC; http://dcic.4dnucleome.org/) 
will store all data generated by the Network, and coordinate data analysis.  The DCIC 
will maintain a web portal to share data, insights and models with the Network and the 
larger scientific community.  A separate Organizational Hub will coordinate all 
communication across the Network and organize regular meetings for all participants of 
the Network. 
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Research Plans 
 
Genomic technologies to reveal the 4D nucleome 
 
Chromosome conformation capture (3C) technologies have been developed to examine 
long-range interactions across the genome 15,18.  Genome-wide 3C technologies, e.g. 
Hi-C, have revealed patterns of interaction that define genome structures at various 
resolutions, including topologically associating domains (TADs) 16,19,20.  TADs can be 
hundreds of kilobases in size, often containing several genes and multiple enhancers, at 
least some of which appear to interact by looping mechanisms.  The ChIA-PET method 
provides finer resolution to detect detailed domain structures defined by chromatin 
architectural proteins such as CTCF and cohesin, as well as specific enhancer-promoter 
interactions associated with RNAPII and other TFs 6.  Furthermore, genome-wide 
mapping at base pair resolution to detect haplotype specific interactions are in progress, 
which will enable the connection of chromatin topology to the vast genetic information 
regarding complex traits and diseases 17,36,37.  The results generated by these and 
related methods have been tremendously exciting, and the Network will continue to 
develop, optimize, and integrate 3C-based technologies with the goal of further 
elucidating the different levels of chromatin interactions in the nucleus, from the local 
nucleosome organization of chromatin polymers to their global 3D organization in 
domains, chromosome territories and in relation to other nuclear structures (Box 1).  
These efforts will be complemented by orthogonal approaches including direct imaging 
technologies at both standard and super resolution, X-ray microscopy, and electron 
microscopy (below and Box 2).  
 
The goal of producing large numbers of data sets of moderate resolution (~1-5 kb) with 
today’s technology is being complemented by an ongoing effort to invent improved 
methods for interaction mapping aimed at delivering additional genome interaction 
information at higher resolution and with haplotype-resolved specificity, lower costs, and 
at the single cell level.  Additional development will also be focused towards 
implementing genome-wide strategies for mapping RNA-DNA interactions (Box 1).  
 
A major limitation of nearly all 3C methods is that they depend on a single cross-linker, 
formaldehyde, or on double cross-linking reagents that combine EGS (ethylene glycol 
bis-succinimidylsuccinate) followed by formaldehyde 38.  Because of the nature of 
formaldehyde, which is known to polymerize and crosslink molecules across a large 
range of distances, this approach complicates the interpretation of the observed 
chromatin contacts as it lacks precise distance information.  The Network will explore 
novel bivalent photo-activated cross-linkers, which have specificity for DNA and are 
separated by linkers of defined length and flexibility.  Other strategies under 
development entirely eliminate the use of cross-linkers.  Additionally, novel genome-
wide methods that enable exploration of higher-order (beyond pairwise) DNA contacts, 
e.g. genomic DNA regions that form hubs, at various resolutions are being developed.  
Finally, new methods are being developed that can assess three dimensional genome 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/103499doi: bioRxiv preprint first posted online Jan. 26, 2017; 
organization in (thousands of) individual cells 39.  Clearly, a diversity of existing and new 
approaches will be necessary to resolve the precise nature of interactions and the 
physical distances separating the interacting DNAs as well as the cell-to-cell variation in 
these patterns.  The resulting data will provide important information for subsequent 
modeling of the structural and functional nature of these interactions. 
 
 
Imaging the 4D genome 
 
4DN investigators will develop and integrate multi-modal imaging platforms that enable 
visualizing the dynamics, interactions, and structural organization of the nucleus at 
unprecedented temporal and spatial resolutions (Box 2).  Each of these imaging 
modalities will have unique and complementary abilities for probing different aspects of 
genome organization both across the cell cycle and during differentiation.  In particular, 
platforms enabling live cell imaging uniquely allow the dynamics of select chromatin 
regions and nuclear features to be studied in real time. 
 
Both standard and high-throughput fluorescent in situ hybridization (FISH) using 
oligonucleotide probes or guide RNA-mediated recruitment of fluorescently labeled 
dCas9 ("CASFISH" 33) in fixed cells will be exploited to image pairwise and multiplexed 
genomic interactions over different spatial distances in different cell types and states. In 
addition, CRISPR/dCas9 FISH in live cells 31,32,40 and other live cell imaging approaches 
(Box 2) will be employed to assay the dynamic behavior of particular chromatin regions 
and/or nuclear structures in real time.  These imaging tools will play an important role in 
benchmarking, validating and complementing data obtained with genomic and 
proteomic mapping technologies.  
 
New technologies will be developed to exploit chemical, nucleic acid, enzymatic and 
fluorescent probes to label DNA, RNA, and protein that occur in proximity of specific 
nuclear bodies.  These technologies include HRP-labeled antibodies in TSA-SEQ (Box 
1), APEX (ascorbate peroxidase; 41) and Killer Red 42.  Many of these same chemicals 
and probes are compatible with more established imaging approaches that will also be 
used to visualize and validate these nuclear body proximity maps.  Genome-editing 
technologies will also be applied to tag a subset of key genomic loci, loops, TADs and 
potentially newly discovered structures to help visualize these moieties and document 
their interactions with other nuclear regions in live cells.  
 
Super resolution microscopy, single-molecule tracking techniques and multiplex 
fluorescent/chemical tags will be applied in living cells to determine the dynamic 
interactions, diffusion and motion of fluorescently labeled proteins, ncRNAs and 
genomic loci (Box 2).  These live cell imaging approaches are expected to provide novel 
information regarding search mechanism, binding and residence time of both DNA and 
protein interactions and will also be relied on extensively to validate and complement 
genomic methods used by the Network.  For example, these methods will be used to 
determine whether the different contact frequencies of loci in 3D genomic maps reflect 
their relative distances in real space and/or their interaction frequency and dynamics.  
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Both imaging and genomics groups will focus on particular TADs and loops to define 
high resolution solutions to the interaction domains of these structures with respect to 
both other chromatin domains and nuclear bodies using the same cell clones growing 
under defined conditions. 
 
Soft X-ray Tomography (SXT) will be used to visualize the 3D organization of chromatin 
in nuclei of cells in the native state (cryo-immobilized).  SXT will be used to directly 
measure chromatin compaction, e.g. in relation to sub-nuclear position, at different 
stages of cell differentiation and in different cell types.  Correlated microscopy 
approaches will be used to augment ultrastructural data with molecular localization 
information.  Cryogenic Fluorescence Tomography (CFT) will be used to precisely 
locate molecules in 3D reconstructions of intact, native state cells imaged using Soft X-
ray Tomography.  
 
Members of the Network will develop new Electron Microscopy (EM) technologies that 
enable the local and global structural organization of chromatin to be visualized as a 
continuum from nucleosome to Mbp scale in both interphase and mitotic cells.  One 
such method, ChromEM, will be combined with new genetic tags and nanoparticle 
labeling technologies to develop the EM equivalent of ‘multi-color’ fluorescence.  
 
The development of automated imaging analysis pipelines and data standards will be 
important to extract the maximum structural information possible from these datasets.  
Further development of software for analyzing, annotating, and archiving imaging data, 
together with implementation of new approaches for correlating imaging and genomics 
datasets are major goals of the 4DN Network (see below). 
 
 
Nuclear bodies and non-chromatin structures  
 
The nucleus consists of distinct nuclear structures as well as non-chromatin bodies, 
including the nuclear lamina, nuclear pores, nuclear speckles, and nucleoli 43,44.  
Increasing evidence indicates that specific genomic regions associate with these 
structures, suggesting that these chromosomal associations may have a functional role 
in regulating genome function 8,45,46.  
 
Major challenges today revolve around our poor understanding and characterization of 
both the structure and function of these nuclear structures and bodies.  Future progress 
in understanding the relationship between nuclear structure and function demands new 
methodologies to study the proximity of different chromosomal loci to these different 
nuclear regions as well as to describe how chromosomal fibers traverse and/or move 
between these different nuclear regions.  Similarly, we envision new technologies to 
interrogate the protein and RNA content of these different nuclear regions.  Additionally, 
we need high-throughput approaches and imaging methods that query the correlations 
between genome localization near these different nuclear regions and changes in the 
functional outputs of these genomic regions.  Likewise, we need new methods to 
dissect the mechanisms by which large genomic regions are targeted to specific nuclear 
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structures / bodies / compartments.  Finally approaches to perturb these nuclear 
structures / bodies /compartments and/or to redirect chromosome regions to different 
nuclear regions will allow assessing the functional significance of nuclear 
compartmentalization. 
 
Goals of the 4D Nucleome Network further include development of new mapping 
methodologies to measure the genome-wide molecular interaction frequency and 
cytological distance of chromosome loci to major nuclear compartments, including the 
nuclear lamina, nuclear pores, nuclear speckles, nucleoli, and pericentric 
heterochromatin (Box 1).  Concurrently, new and improved technologies will be 
developed, including localized APEX (ascorbate peroxidase)-mediated protein 
biotinylation 47, fractionation by cryomilling, and RNA Antisense Purification (RAP) (48-
50), to catalog and measure the protein and RNA components of these nuclear 
compartments, as well as both optogenetic and degron-based approaches to alter or 
disrupt sub-nuclear bodies and compartments.  Functional mapping approaches based 
on Repli-Seq 9 and TRIP (thousands of reporters integrated in parallel; 51) will provide 
genome-wide correlations of DNA replication timing and chromosome position effects 
on transcription and RNA processing that can be correlated with these structural maps 
(Box 1).  New imaging approaches will be developed to correlate chromosome and 
nuclear compartment dynamics with changes in DNA replication timing, transcriptional 
activation, and other functional states (Box 2).  Computational analyses of these 
genome mapping data from several cell types will be aimed at identifying possible cis 
and trans determinants of nuclear compartmentalization.   
 
 
Modeling the 4D Nucleome 
 
As described above, the 4DN network will develop an increasingly powerful repertoire of 
tools for generating high-throughput data that inform us about 3D/4D nuclear 
architecture.  The major classes of methods yield data that are informative with respect 
to biochemically-derived contact probabilities of loci (e.g. 3C and its derivatives) or the 
spatial distances between loci (e.g. FISH and other imaging methods).  Additional 
technologies yield data that are informative of other aspects of nuclear architecture (e.g. 
the relative positions and contents of nuclear structures in relation to one another as 
well as the folded genome). 
 
In parallel and often in concert with the emergence of these experimental methods has 
been the development of computational approaches for modeling the spatial 
organization of the genome.  There are at least two major computational approaches for 
global modeling of genome architecture on the basis of experimental data: data-driven 
and de novo approaches 34,35.  Data-driven approaches directly use experimental data 
to produce a single conformation or an ensemble of conformations that best match an 
experimentally observed set of contact probabilities or distances 52.  De novo modeling, 
on the other hand, produces ensembles of conformations that result from known or 
hypothesized physical or biological processes, and tests whether these ensembles are 
consistent with features of experimental contact frequency maps and imaging data.  
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Such de novo models can suggest specific molecular mechanisms and principles of 
chromosome organization, thus going far beyond the experimental data 35. 
 
Although these approaches to modeling genome architecture have been useful for 
making sense of the observed data and relating it to principles of chromosome 
organization, it is clear that we are still far from a high-confidence, high-resolution map 
of genome architecture.  Therefore, an overarching goal of the Network is to generate 
reliable and validated structural maps representing the 4D Nucleome for different 
biological states of the genome. 
 
A number of challenges and opportunities with respect to computational modeling of 
genome architecture will be addressed.  First, computational models of global genome 
architecture have typically relied on a single data type, e.g. Hi-C, which limits the power 
of such analyses because it is likely that Hi-C or ChIA-PET or any other one method 
does not capture all aspects of the 4D nucleome and does not sufficiently constrain 
models.  The Network will apply a wide diversity of technologies, and each of these is 
likely to capture complementary aspects of genome organization, e.g. contacts by Hi-C 
and distances by imaging 53,54.  A major challenge is thus to adapt current modeling 
approaches so that data obtained with these methods (e.g. Hi-C and imaging data) can 
be systematically integrated and used to generate comprehensive structural and 
dynamic models of the 4D nucleome.  Second, nearly all current genomic methods yield 
data that are derived from an ensemble of thousands to millions of cells, obscuring 
structural heterogeneity that exists among single cells.  A number of groups within the 
Network are developing methods for generating global data from large numbers of 
single cells, which will present new computational challenges for integrating with current 
modeling approaches 39.  It is possible that some of these methods will yield functional 
data on these same single cells (i.e. Hi-C and RNA-seq, from each of many single 
cells), which would represent a significant opportunity for directly relating structure to 
function.  Third, most current models ignore the fact that mammalian cells are diploid, 
i.e. they do not distinguish or separately model homologous chromosomes, which will 
be particularly important for modeling based on single-cell data.  It is critical to develop 
experimental methods and computational pipelines that overcome this deficiency 17,36,37; 
the haplotype-resolution of the genomes of the common cell types chosen by the 
consortium will aid in this goal.  Fourth, contemporary approaches for modeling genome 
architecture are typically static rather than dynamic, reflecting the static nature of 
available Hi-C data and the majority of imaging data.  As we are increasingly able to 
visualize (via direct imaging) or infer (via single cell or bulk Hi-C analyses of time series, 
live cell imaging) dynamic processes, e.g. differentiation, response to physiological 
stimuli, and cell cycle progression, it will be essential that these observations can be 
integrated into computational models.  Fifth, new data and future models should help to 
connect genome architecture and other aspects of genome function, e.g. by suggesting 
molecular mechanisms of how transcription factor binding or epigenetic modifications 
can lead to formation of active/inactive chromatin compartments 55,56, etc.  The inferred 
relationships between these features and genome architecture would serve as a means 
of generating testable predictions of sequence-structure-function relationships, i.e. how 
nuclear architecture relates to nuclear function. 
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Perturbation and manipulation of the 4D Nucleome to relate structure to function 
 
A critical and overarching goal is to determine how genome structure and chromatin 
interactions at multiple scales modulate genome function in health and disease.  
However, despite significant progress, many of the mechanisms by which chromosome 
structures such as chromatin domains are formed and how they are related to local 
genome activity remain poorly understood. 
 
Therefore, the 4DN Network will explore a range of experimental approaches to 
specifically manipulate and perturb different features of the 4DN.  First, using 
CRISPR/Cas9 technologies and targeted DNA integration experiments, DNA elements 
involved in specific chromatin structures, e.g. domain boundaries or chromatin loops, 
can be altered, re-located or deleted 57,58.  Second, defined chromatin structures such 
as chromatin loops will be engineered de novo by targeting proteins that can (inducibly) 
dimerize with their partner looping proteins (e.g. 7).  Third, other CRISPR/Cas9 
approaches will be used to target enzymes (e.g. histone modifying enzymes, structural 
proteins) or ncRNAs to specific sites in the genome.  Fourth, several groups will perturb 
nuclear compartmentalization by developing methods for “rewiring” chromosome 
regions to different nuclear compartments, either by integrating specific DNA sequences 
that are capable of autonomous targeting the locus to different nuclear compartments or 
bodies or by tethering certain proteins to these chromosomal loci to accomplish similar 
re-positioning.  Fifth, cell lines will be generated for conditional/temporal ablation of 
nuclear bodies or candidate chromosome architectural proteins (such as CTCF and 
cohesin) or RNAs.  Sixth, additional methods will be developed to nucleate nuclear 
bodies at specific chromosomal loci.  Finally, biophysical approaches will be developed 
to micro-mechanically perturb cell nuclei and chromosomes followed by direct imaging 
of specific loci 59.  Analysis of the effects of any of these perturbations on processes 
such as gene expression and DNA replication will then provide deeper mechanistic 
insights into the roles of chromosome structure and nuclear organization in regulating 
the genome. 
 
 
Data sharing and standards 
 
An important goal for the Network will be to develop practical guidelines for data 
formats, metadata (detailed descriptions of how the data was acquired), standards, 
quality control measures, and other key data-related issues.  Another goal will then be 
to make this production-quality data rapidly and readily accessible, both within the 
Network and the entire scientific community.  These efforts will be of particular 
importance for new technologies for which standards for sharing data and assessing 
data quality have not yet been established.  Such standards will greatly enhance the 
usefulness of the datasets for the broader scientific community beyond those who 
generate the data.  
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For sequencing-based technologies, data format standards to represent sequences and 
alignments have long been present (e.g. fastq, bam/sam).  However, common formats 
to represent three-dimensional interactions are yet to be developed.  These formats 
need to account for large data sizes and the constraints imposed by different computer 
architectures. For Hi-C data, for example, the genome-wide contact probability map is 
an N^2 matrix, where N is the spatial resolution (for 10kb resolution, N=300,000), with 
most of the entries being empty; whereas for ChIA-PET data the detected chromatin 
contacts are between selected loci bound by a protein of interest, which greatly reduces 
the complexity of the interaction matrix.  There are multiple ways to represent such 
sparse matrices, appropriate for different analysis and storage approaches.  For 
imaging technologies, the situation is even more challenging, as the types of 
microscopes employed are highly variable, and the data formats and analysis tools are 
often manufacturer-dependent.  Standards to unify data and metadata from different 
manufacturers, such as the Open Microscopy Environment 
(https://www.openmicroscopy.org/site), are under development.  These standards also 
need to accommodate the rapid and ongoing developments in super-resolution 
microscopy technologies. 
 
A related issue is to define a set of appropriate metadata fields and minimum metadata 
requirements such that sufficient and useful details are available to other investigators 
outside the Network.  While it is acknowledged that not all information can be captured 
about an experiment, collecting pertinent information (without unnecessarily burdening 
the experimentalists) will increase the reproducibility of experiments and the likelihood 
that the data will be re-used by other investigators.  Towards this end, the 4DN 
Consortium has established formal working groups, including the 4DN Data Analysis 
Group, Omics Standards Group and Imaging Data Standards Group, which will play 
critical roles in defining these 4DN standards and data analysis protocols. 
 
Developing a set of measures for assessing data quality and determining appropriate 
thresholds will be important for ensuring high-quality 4DN data.  An important measure 
of data quality and reliability of new technologies is the reproducibility of results between 
repeated experiments. Reproducibility can be assessed at multiple levels: broadly 
speaking, technical reproducibility measures how well a technique performs for the 
same starting material, whereas biological reproducibility should also capture all other 
variations including heterogeneity among samples.  Data quality standards and 
thresholds for what constitutes ‘good’ data will change over time as technologies 
improve and analysis methods are refined.  To accommodate this fluidity, the 4DN 
Analysis Group will compute and make available relevant quality control measures and 
provide recommendations on expected quality standard thresholds so that investigators 
can make decisions regarding the utility of specific datasets for addressing their specific 
questions.   
 
 
Outlook 
After determining the complete DNA sequence of the human genome, the variations in 
this sequence in individuals and across populations, and mapping most genes and 
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potential regulatory elements, we are now in a position that can be considered the third 
phase of the human genome project.  In this phase, the spatial organization of the 
genome is elucidated and its functional implications revealed.  This requires a wide 
array of technologies from the fields of imaging, genomics, genetic engineering, 
biophysics, computational biology and mathematical modeling.  The 4D Nucleome 
Network, as presented here, provides a mechanism to address this uniquely 
interdisciplinary challenge.  Further, the policy of openness and transparency both 
within the Network and with the broader scientific community, and the public sharing of 
all methods, data and models will ensure rapid dissemination of new knowledge, further 
enhancing the potential impact of the work.  This will also require fostering 
collaborations and establishing connections to other related efforts around the world 
that are currently under development. 
Together these highly integrated studies, both within the 4DN Network, and with 
partners around the world, promise to allow moving from a one-dimensional 
representation of the genome as a long DNA sequence to a spatially and dynamically 
organized three dimensional structure of the living genome inside cells.  This structure 
will place genes and regulatory elements that can be far apart along the DNA, in a 
three-dimensional and dynamic context, revealing their functional relationships and 
providing a new understanding of how the genome is regulated. 
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Figure 1.  The 4D Nucleome project.  The project encompasses three components:  
First, experimental mapping approaches are employed to measure a range of aspects 
of the spatial organization of the genome including chromatin loops, domains, nuclear 
bodies etc.  Second, computational and modeling approaches are used to interpret 
experimental observations and build (dynamic) spatial models of the nucleus.  Third, 
perturbation experiments, e.g. using CRISPR/cas9-mediated genome engineering, are 
used for functional validation.  In these studies chromatin structures are altered, e.g. 
removing chromatin loops or inducible creating novel loops at defined positions.  These 
perturbation studies can be complemented with functional studies, e.g. analysis of gene 
expression to assess the functional implications of chromatin folding.  (Picture of cell 
nucleus was provided by Hanhui Ma and Thoru Pederson). 
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Figure 2. Organization of the 4D Nucleome Network.  Six interdisciplinary centers 
make up the Nuclear Organization and Function Interdisciplinary Consortium.  Three 
additional groups of funded projects focus on analysis of nuclear bodies and 
development of nucleomics and imaging tools.  A Data Coordination and Integration 
Center collects all data for analysis and public sharing.  The Organizational Hub 
coordinates all Network activities. 
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Table 1: Common cell lines used by the 4D Nucleome network.  Tier 1 cells are used 
for all studies, while Tier 2 cell lines are used for specific projects. 
 
Tier 1 Description Availability 
H1-ESC (WA01) Human embryonic stem cells (male) WiCell 
hTert-HFF hTert-immortalized human foreskin fibroblasts (male) Dekker lab 
IMR90 Primary breast fibroblasts (female) ATCC 
GM12878 EBV-immortalized B-lymphocytes (female) Coriell 
F121-9 Mouse Cast-129 F1 hybrid embryonic stem cells (female) Gilbert lab 
 
Tier 2 Description Availability 
K562 Chronic myelogenous leukemia (female) ATCC 
hTert-RPE hTert-immortalized retina pigmented epithelium (female) ATCC 
HEK293 Human embryonic kidney (likely female) ATCC 
U-2 OS Osteosarcoma cells (female) ATCC 
HAP1 Haploid derivative of chronic myelogenous leukemia 
(CML) cell line KBM-7 (male) 
Horizon 
Genomics 
WTC-11 iPSC (male) TBD 
F123 Mouse Cast-129 F1 hybrid embryonic stem cells (male) TBD 
H9-ESC (WA09 Human embryonic stem cells (female) TBD 
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Box 1: Genomic technologies currently in use or in development in the 4DN network  
 
      
Assay Name Assay Abr. Key features Reference Related 
Protocols 
 
    
Chromosome 
Conformation 
Capture 
 
 
3C 
 
4C 
 
5C 
Hi-C 
 
Single Cell Hi-C 
 
Combinatorial  
single-cell Hi-C 
In situ Hi-C 
 
DNase Hi-C 
 
Micro-C 
 
Capture Hi-C 
 
TCC 
 
Distance Hi-C 
 
 
COLA 
 
 
 
All methods use proximity ligation to 
measure interacting genomic loci 
Interactions between specific genomic loci, 
including genome-wide studies 
Genome-wide interactions of a specific 
genomic locus 
Many loci against many loci 
Genome wide map of all interactions in the 
nucleus 
Hi-C variant that enables mapping contacts 
within single cells 
Single cell Hi-C variant using split-pool 
barcoding to map single cells 
Hi-C variant that performs digestion and 
ligation in intact nuclei 
Hi-C variant that digests chromatin using 
DNase 
Hi-C variant that digests chromatin using 
micorcoccal nuclease 
Hi-C variant that incorporates selection of 
targeted genomic loci 
A variant of Hi-C using bead-coupling of 
complexes 
Variant of Hi-C using photo-activated 
crosslinkers to measure the distance 
between interacting DNA regions. 
A variant of Hi-C using frequent restriction 
cutters to map >2 simultaneous DNA 
interactions 
 
 
 
15,60
 
 
61
 
62
 
16
 
 
39
 
http://biorxiv.org/con
tent/early/2016/07/2
3/065052 
17
 
63
 
64
 
65,66
 
 
67
 
 
 
 
68
 
 
 
 
 
 
69-71
 
 
72,73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74
 
Chromatin 
Interaction 
Analysis by 
paired-end-tag 
sequencing 
ChIA-PET Genome-wide map of interactions co-
occurring with a specific protein. 
6,38
  
Genome 
Architecture 
Mapping 
GAM A cryosectioning method to get interacting 
DNA regions in a ligation-independent 
manner. Can achieve higher-order 
interactions. 
Under 
development 
 
Split-pool 
 A ligation-independent method using a split- Under  
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barcoding of 
RNA and DNA 
and-pool strategy to barcode interacting RNA 
and DNA in the nucleus that enables 
genome-wide mapping of higher-order 
contacts. 
development 
RNA 
interaction 
with chromatin 
by paired-end-
tag 
sequencing  
RICh-PET Genome-wide mapping for all ncRNA-
chromatin interactions.  
Under 
development 
 
Chromatin IP 
aided RICh-
PET 
ChIP RICh-PET Genome-wide mapping for 3-way interactions 
involving ncRNA, DNA loci, and protein 
factors.  
Under 
development 
 
DNA Adenine 
Methyltrans-
ferase 
Identification 
DamID and Single-
Cell DamID 
 
 
 
 
 
Genome-wide mapping of molecular contact 
frequency of DNA locus to a Dam methylase 
fusion protein: will be used to measure DNA 
proximity to different nuclear compartments 
75,8,76; under 
development 
77,78
 
Tyramide 
Signal 
Amplification- 
Seq 
TSA-Seq Genome-wide mapping of estimated mean 
cytological distance (in microns) of DNA 
locus to a nuclear compartment; will be used 
to map cytological distances to several 
nuclear compartments 
Under 
development 
 
Replication 
Labeling-Seq 
Repli-Seq  Genome-wide mapping of timing of DNA 
replication 
79,80
 
 
81
 
Thousands of 
Reporters 
Integrated in 
Parallel 
TRIP Genome-wide mapping of chromosome 
position effects on transcription and post-
transcriptional processing 
51
 
82
 
RNA 
Antisense 
Purification 
RAP Systematic mapping of DNA regions, RNA 
species, and proteins that are in proximity to 
a specific noncoding RNA of interest in the 
nucleus.  
48-50
 
83,84
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Box 2: Imaging technologies currently in use or in development in the 4DN network  
 
 
     
Application Method Label/Stain/Dye Feature References 
 
Visualizing DNA 
and RNA 
sequences 
 
3D DNA and RNA 
FISH 
 
 
HIPMap  
 
 
 
 
LacO and TetO 
labeled genomic loci 
 
 
 
 
 
Cas-FISH and Cas 
live cell imaging 
 
 
 
 
 
CRISPRainbow 
 
 
 
 
 
MERFISH 
 
 
TALE-FISH 
 
 
 
 
 
MS2, PP7, mSpinach, 
aptamers  
 
Fluorescently labeled 
DNA and RNA oligo 
probes  
 
High throughput FISH 
 
 
 
 
Lac-O and Tet-O repeats 
inserted into genome, 
visualized by 
fluorescently labeled lac 
and tet repressor 
proteins 
 
Fluorescently labeled 
dCas9 and guide RNAs 
to label genomic loci 
 
 
 
 
gRNA contains stem loop 
that is bound by 
fluorescently labeled coat 
protein 
 
 
Multiple detection of up 
to 1000 mRNA species 
 
Fluorescent TALE 
fusions that label specific 
genomic loci with 
naturally occurring 
repeats 
 
Fluorescent fusions that 
bind and label tagged 
RNA sequences 
 
 
Fixed cells 
 
 
 
High throughput FISH 
and automated 
microscopy in fixed 
cells 
 
Can be used in live and 
fixed stable cell-lines 
 
 
 
 
 
Live and fixed cells- 
guide RNAs against 
repetitive targets 
and/or collections of 
guide RNAs that cover 
unique sequences 
 
Live cell imaging of 
repetitive DNA targets 
and/or unique 
sequences using 
collections of gRNAs 
 
 
 
 
Live and fixed cells 
 
 
 
 
 
Live and fixed cells 
 
 
 
 
 
85
 
 
 
 
 
86
 
 
 
 
 
 
 
32,40,33
 
 
 
 
 
 
 
31,87
  
 
 
 
 
 
 
 
 
88,89
 
 
Labels and tags Fluorescent 
 
 
 
 
Photo-activated and 
Photo-switchable 
 
 
 
 
 
 
Peroxidases 
Correlated light and 
EM 
 
 
 
 
 
GFP, mCHERRY, Killer-
RED, Dendra  
Suntag, SH2 
Quantum dots 
 
PA-
GFP/MCherry/mKATE 
TAG-RFP,  
Dronpa, Alexa-
488/568/647 
PS-CFP2,  
Eos, atto488, Cy5 etc 
 
HRP, APEX, APEX2 
miniSOG 
ChromEM 
ALEXA 633 
Fluoronanogold  
Time-STAMP-YFP-
MiniSOG 
 
Imaging live and fixed 
cells-diffraction limited 
  
 
 
super resolution 
stochastic imaging, 
single-molecule 
tracking, live and fixed 
cells 
 
 
 
For labeling in electron 
microscopy, sometimes 
combined with 
correlative light and 
electron microscopy 
(CLEM) 
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Clickable tags 
Janelia Fluor dyes: 646, 
549 etc  
 
Snap and Halo tags 
 
 
 
 
Genetically encoded 
tags for live and fixed 
cell imaging 
 
90
 
 
 
 
High Resolution 
Ultrastructure 
and 3D 
organization  
Transmission EM 
 
 
 
 
 
 
 
Serial Block Face 
Scanning EM (SBEM) 
 
 
 
 
Mult-tilt EM 
Tomography 
 
 
 
 
 
 
Serial section EMT 
(ssEMT) 
 
 
 
 
X-Ray Tomography 
 
 
 
 
 
 
 
Correlated SIM and 
X-Ray Tomography 
 
 
 
 
 
 
 
Multi-Color EM (EELS 
and EMT) 
 
 
 
 
 
Heavy metal stains-
Osmium tetroxide, Uranyl 
acetate, lead. Colloidal 
goal and nanogold 
labels. 
CLEM inorganic and 
organic probes and tags 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quantitative linear 
absorption coefficient 
(LAC) generated contrast 
that reflects the 
bioorganic composition of 
unlabeled DNA, RNA and 
proteins 
 
Fluorescently labeled 
probes 
 
 
 
 
 
 
 
Orthogonal correlated 
light and EM probes and 
DAB conjugates to 
visualize chromatin and 
proteins/ RNA in the 
nucleus  
 
2D transverse 
projection through 70-
250 nm sections 
 
 
 
 
 
Reconstruction and 
scanning EM images of 
serial sections (70 nm) 
through entire 
cell/tissue volume  
 
High resolution 
ultrastructure of 
macromolecules in situ 
through large 3D 
volumes (250-400 nm 
thick sections) of the 
nucleus 
 
Reconstruction of 
larger 3D volumes 
(>500nm thick) by 
alignment of serial 
EMT datasets  
 
Mesoscale resolution 
(20-50 nm) of nuclear 
structure in intact, 
unprocessed cells  
 
 
 
 
Visualizing the 
structure and 
interactions of 
selectively labeled 
chromatin and protein 
interactions in intact, 
unprocessed whole 
cells 
 
Visualizing the 
ultrastructure and 
interactions of 
selectively labeled 
chromatin and protein 
interactions 
simultaneously 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91
 
 
 
 
 
 
 
 
92
 
 
 
 
 
 
 
 
 
93
 
 ChromEMT ChromEM labeling of 
chromatin and 8-tilt EMT 
Enables the local 
ultrastructure and 
global 3D organization 
of chromatin as a 
continuum at 
nucleosome 
resolutions and 
megabase scales in 
single cells 
 
Under 
development 
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Visualizing 
spatial and 
dynamic 3D 
nuclear 
organization 
 
 
 
Wide-field, 
Confocal/Multiphoton 
 
3D SIM 
PALM 
STORM 
STED 
 
Adaptive Optics 
 
 
tcPALM 
 
 
Lattice Light Sheet 
(LLS) 
LLS-PAINT 
 
Single-molecule 
tracking in live cells 
FCS 
FRAP 
FRET 
FLIP 
 
 
 
Diffraction limited 
(>250 nm) 
 
Super-resolution 
imaging of nuclear 
organization in fixed 
cells (ca. 20 nm). 
 
3D resolution in 
PALM/STORM  
 
Nuclear organization in 
live cells  
 
3D dynamics and 
nuclear organization  
 
 
Dynamics 
Allows measurements 
of binding and search 
dynamics (residence 
time, search time, 
search mechanism)  
 
 
 
 
 
 
 
 
94
 
 
 
30
 
 
 
95,96
 
 
 
 
97-99
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